NCT06533007View on ClinicalTrials.gov

PDE3B in Metabolic Regulation

Not yet recruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2024

Primary Completion Date

September 30, 2028

Study Completion Date

September 30, 2029

Conditions
Type 2 DiabetesCardiometabolic SyndromeCardiovascular Diseases
All Listed Sponsors
collaborator

University of Cambridge

OTHER

lead

Cambridge University Hospitals NHS Foundation Trust

OTHER